These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6140315)

  • 1. Cardiovascular alpha 2-receptors.
    van Zwieten PA; Timmermans PB
    J Mol Cell Cardiol; 1983 Nov; 15(11):717-33. PubMed ID: 6140315
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment.
    Van Zwieten PA; Timmermans PB; Van Brummelen P
    Am J Med; 1984 Oct; 77(4A):17-25. PubMed ID: 6148891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo analysis of alpha-adrenoceptors in pial veins of cats.
    Ulrich K; Kuschinsky W
    Acta Physiol Scand Suppl; 1986; 552():37-40. PubMed ID: 2880453
    [No Abstract]   [Full Text] [Related]  

  • 4. Central alpha-adrenoceptors in cardiovascular regulation.
    Gross F
    Chest; 1983 Feb; 83(2 Suppl):293-6. PubMed ID: 6129944
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral alpha 1- and alpha 2-adrenoreceptor mechanisms in blood pressure control.
    Reid JL; Hamilton CA; Hannah JA
    Chest; 1983 Feb; 83(2 Suppl):302-4. PubMed ID: 6129947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-adrenergic vasoconstriction and receptor subtypes in large coronary arteries of calves.
    Young MA; Vatner DE; Knight DR; Graham RM; Homcy CJ; Vatner SF
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1452-9. PubMed ID: 2904772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
    Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
    Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of contrasting properties of alpha 1/alpha 2 systems.
    Timmermans PB; Thoolen MJ; De Jonge A; Wilffert B; Van Zwieten PA
    Clin Sci (Lond); 1985; 68 Suppl 10():93s-97s. PubMed ID: 2857626
    [No Abstract]   [Full Text] [Related]  

  • 10. Are the pre- and postsynaptic alpha-adrenoceptors in human vascular smooth muscle atypical?
    Stevens MJ; Moulds RF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S129-33. PubMed ID: 6175826
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity of post-junctional alpha-adrenoceptors in human vascular smooth muscle.
    Stevens MJ; Moulds RF
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):43-57. PubMed ID: 6121538
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship of receptor reserve and agonist efficacy to the sensitivity of alpha-adrenoceptor-mediated vasopressor responses to inhibition by calcium channel antagonists.
    Ruffolo RR; Nichols AJ
    Ann N Y Acad Sci; 1988; 522():361-76. PubMed ID: 2897818
    [No Abstract]   [Full Text] [Related]  

  • 13. The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade.
    van der Starre PJ; Reneman RS
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S54-61. PubMed ID: 2459516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
    Jagadeesh G; Deth RC
    J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1-adrenoceptor stimulation induces nitric oxide release in rat pulmonary arteries.
    Boer C; Scheffer GJ; de Lange JJ; Westerhof N; Sipkema P
    J Vasc Res; 1999; 36(1):79-81. PubMed ID: 10050076
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological characterisation of pre- and postsynaptic alpha-adrenoceptors in dog saphenous vein.
    Sullivan AT; Drew GM
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(3):249-58. PubMed ID: 6112714
    [No Abstract]   [Full Text] [Related]  

  • 17. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
    Eltze M; Boer R
    Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation.
    van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A
    Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of [3H]prazosin to porcine aortic membranes: interaction of calcium antagonists with vascular alpha-1 adrenoceptors.
    Nishimura J; Kanaide H; Nakamura M
    J Pharmacol Exp Ther; 1986 Mar; 236(3):789-93. PubMed ID: 3005556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium handling in vasoconstriction to stimulation of alpha 1- and alpha 2-adrenoceptors.
    Timmermans PB; Chiu AT; Thoolen MJ
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1649-57. PubMed ID: 2891423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.